09:08 AM EDT, 03/15/2024 (MT Newswires) -- Michael Secora, Chief Financial Officer, around March 12, 2024, sold 50,000 shares in Recursion Pharmaceuticals ( RXRX ) for $537,190. Following the Form 4 filing with the SEC, Secora has control over a total of 1,204,179 shares of the company, with 1,204,179 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1601830/000160183024000023/xslF345X03/wk-form4_1710458910.xml

Price: 10.86, Change: +0.08, Percent Change: +0.74